Low-Risk Myelodysplastic Syndrome (LR-MDS)
1 clinical trials · Condition
◉ Watch Low-Risk Myelodysplastic Syndrome (LR-MDS)
| Record | Firm | Date |
|---|---|---|
| Safety and Tolerability of REGN17235 in Adult Participants With Clonal Cytopenia of Undetermined Significance and Low-Risk Myelodysplastic Syndrome With SF3B1 Mutation (NCT07753148) | Regeneron Pharmaceuticals | 2026-09-17 |
Track Low-Risk Myelodysplastic Syndrome (LR-MDS) automatically
Every clearance here is in the API, with alerts when new ones post.